TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25937633

Group type: EXPERIMENTAL
Intervention: TM208 (50 and 150 mg·kg ‐1 ·d ‐1) for 18 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TM208 (10, 15 and 20 μmol/L) in vitro
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tamoxifen (positive control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Co-treatment with triclosan (inhibitor of sulfonation)
Number of subjects: 0
Study: 24006895

Group type: EXPERIMENTAL
Intervention: Multiple letters to parents
Number of subjects: 11088

Group type: EXPERIMENTAL
Intervention: Financial incentive to school
Number of subjects: 11088

Group type: EXPERIMENTAL
Intervention: Financial incentive to school administrator plus direct mailing to parents
Number of subjects: 11088

Group type: EXPERIMENTAL
Intervention: Promoting the research by providing additional information to parents and children
Number of subjects: 11088

Group type: COMPARATOR
Intervention: Control intervention (usual practice: single letter home to parents)
Number of subjects: 11088
Study: 21035276

Group type: EXPERIMENTAL
Intervention: Alcoholics Anonymous (AA) attendance
Number of subjects: 1726
Study: 18991970

Group type: EXPERIMENTAL
Intervention: Learning Through Play programme
Number of subjects: 309

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 309
Study: 16500776

Group type: EXPERIMENTAL
Intervention: MoodGYM (cognitive behaviour therapy Internet program)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard personal development activities (control group)
Number of subjects: 78
Study: 15611398

Group type: EXPERIMENTAL
Intervention: Injections of botulinum toxin type A into the thyroarytenoid muscle(s)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 42
Study: 11014954

Group type: EXPERIMENTAL
Intervention: Weekly oral dose of 150 mg fluconazole for 6 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low oxalate diet with calcium citrate (placebo)
Number of subjects: 40
Study: 9293648

Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline at 7 ml/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isotonic lactated Ringer's solution at 7 mg/kg
Number of subjects: 60
Study: 8299637

Group type: EXPERIMENTAL
Intervention: Alteplase 100 mg infused over 3 h
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 3571088

Group type: EXPERIMENTAL
Intervention: Reinfusion of 600 ml of NaCl-glucose-phosphate solution with approximately 50% hematocrit (n = 6)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline solution (n = 3)
Number of subjects: 9
Study: 2827941

Group type: EXPERIMENTAL
Intervention: Pregnancy (second and third trimesters)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post partum
Number of subjects: 0

Group type: COMPARATOR
Intervention: High sodium intake (greater than 250 mmol/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low sodium intake (less than 50 mmol/day)
Number of subjects: 0
Study: 31638942

Group type: EXPERIMENTAL
Intervention: Specialist physiotherapy protocol
Number of subjects: 264

Group type: COMPARATOR
Intervention: Treatment as usual (referral to a community physiotherapy service)
Number of subjects: 264
Study: 29186803

Group type: EXPERIMENTAL
Intervention: Health Star Rating (HSR)
Number of subjects: 1578

Group type: EXPERIMENTAL
Intervention: Multiple Traffic Light labels (MTL)
Number of subjects: 1578

Group type: EXPERIMENTAL
Intervention: Daily Intake Guides (DIG)
Number of subjects: 1578

Group type: EXPERIMENTAL
Intervention: Recommendations/Warnings (WARN)
Number of subjects: 1578

Group type: COMPARATOR
Intervention: Nutrition Information Panel (NIP)
Number of subjects: 1578
Study: 25406306

Group type: EXPERIMENTAL
Intervention: Irbesartan in Heart Failure with Preserved systolic function trial (I-Preserve)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM)-Preserved trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: HF-REF in Western Europe
Number of subjects: 0

Group type: COMPARATOR
Intervention: HF-PEF and HF-REF
Number of subjects: 0
Study: 23513399

Group type: EXPERIMENTAL
Intervention: Oral conjugated estrogens and medroxyprogesterone (0.625 mg/d plus medroxyprogesterone 5 mg/d for 10 days)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo pills
Number of subjects: 111

Group type: COMPARATOR
Intervention: Premenopausal women
Number of subjects: 111
Study: 21546627

Group type: EXPERIMENTAL
Intervention: CEM‐102 (fusidic acid) administered in single, multiple, and loading doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loading doses of CEM‐102
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CEM‐102 (fusidic acid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19528807

Group type: EXPERIMENTAL
Intervention: Propofol alone
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Propofol and fentanyl
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Propofol and midazolam
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Propofol, midazolam and fentanyl
Number of subjects: 200
Study: 16917133

Group type: EXPERIMENTAL
Intervention: Dynamic bubble trap (DBT) introduced into the arterial line of ECC
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo-DBT
Number of subjects: 41
Study: 15523294

Group type: EXPERIMENTAL
Intervention: Low-dose nesiritide (0.015 microg/kg/min)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: High-dose nesiritide (0.03 microg/kg/min)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Dobutamine (>= 5 microg/kg/min)
Number of subjects: 185
Study: 11744418

Group type: EXPERIMENTAL
Intervention: Tacrolimus (FK506)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Total lymphoid irradiation
Number of subjects: 13
Study: 9423913

Group type: EXPERIMENTAL
Intervention: pH-adjusted lidocaine 4%
Number of subjects: 34

Group type: COMPARATOR
Intervention: standard lidocaine 4%
Number of subjects: 34
Study: 7506144

Group type: EXPERIMENTAL
Intervention: Nimesulide 200 mg/day
Number of subjects: 200

Group type: COMPARATOR
Intervention: Seaprose S 60 mg/day
Number of subjects: 200
Study: 3101609

Group type: EXPERIMENTAL
Intervention: LNT injection following surgical therapy (Ax + Ox)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: LNT injection
Number of subjects: 33

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 33

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 33
Study: 29128558

Group type: EXPERIMENTAL
Intervention: 35% CO2 inhalation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo gas
Number of subjects: 20
Study: 26673586

Group type: EXPERIMENTAL
Intervention: Prophylactic nebulised heparin (50,000 U)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 25155048

Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery (CAS)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard instrumentation
Number of subjects: 95

Group type: COMPARATOR
Intervention: Both CAS and standard instrumentation
Number of subjects: 95

Group type: COMPARATOR
Intervention: Entire patient population
Number of subjects: 95
Study: 22184381

Group type: EXPERIMENTAL
Intervention: Docetaxel plus vandetanib (100 mg)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Docetaxel plus placebo
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Single-agent vandetanib (after crossover)
Number of subjects: 142
Study: 19949861

Group type: EXPERIMENTAL
Intervention: Internal urethrotomy with submucosal injection of triamcinolone (40 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Internal urethrotomy without triamcinolone (control group)
Number of subjects: 50
Study: 17967221

Group type: EXPERIMENTAL
Intervention: Strontium ranelate (SR) treatment for 3 years
Number of subjects: 465
Study: 16002025

Group type: EXPERIMENTAL
Intervention: LAAM (100, 100, 130 mg/MWF) with contingency management (CM)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: LAAM (100, 100, 130 mg/MWF) without CM
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: LAAM (30, 30, 39 mg/MWF) with CM
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: LAAM (30, 30, 39 mg/MWF) without CM
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: LAAM (100, 100, 130 mg/MWF) with CM
Number of subjects: 140
Study: 11833838

Group type: EXPERIMENTAL
Intervention: Combination hydrocodone 7.5 mg and ibuprofen 200 mg (HC/IB)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Combination oxycodone 5 mg and acetaminophen 325 mg (OX/AC)
Number of subjects: 147
Study: 10189543

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention focusing on a healthy diet and exercise
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Metformin combined with standard diet and exercise recommendations
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Placebo combined with standard diet and exercise recommendations
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Troglitazone combined with standard diet and exercise recommendations
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Standard diet and exercise recommendations
Number of subjects: 3000
Study: 7559264

Group type: EXPERIMENTAL
Intervention: Azelastine 4 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2373136

Group type: EXPERIMENTAL
Intervention: Terguride 50 micrograms i.v. dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terguride 250 micrograms oral treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terguride 500 micrograms oral treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terguride 750 micrograms oral treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terguride (all doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terguride
Number of subjects: 0
Study: 7295072

Group type: EXPERIMENTAL
Intervention: Combination of anticholinergics, sulphoglicopeptide and sucralfate
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Anticholinergic plus sucralfate
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 29460712

Group type: EXPERIMENTAL
Intervention: Rhythmic alpha stimulation (RAS)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Rhythmic delta stimulation (RDS)
Number of subjects: 22
Study: 29506563

Group type: EXPERIMENTAL
Intervention: Community engagement intervention delivered in 10 wards
Number of subjects: 1450

Group type: COMPARATOR
Intervention: Normal practice in 10 comparator wards
Number of subjects: 1450
Study: 27555188

Group type: EXPERIMENTAL
Intervention: GlideScope® classic (GSc)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: GlideScope® direct (GSd)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Direct laryngoscopy (DL)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Video laryngoscopy
Number of subjects: 104
Study: 24913546

Group type: EXPERIMENTAL
Intervention: Less encompassing instructions
Number of subjects: 0

Group type: COMPARATOR
Intervention: More encompassing instructions
Number of subjects: 0
Study: 22380600

Group type: EXPERIMENTAL
Intervention: High intensity back endurance (HIBE) training
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low intensity abdominal (LOAB) training (control)
Number of subjects: 26
Study: 19708170

Group type: EXPERIMENTAL
Intervention: Zidovudine prophylaxis
Number of subjects: 979

Group type: EXPERIMENTAL
Intervention: Subgroups identified as 'at risk' based on factors
Number of subjects: 979
Study: 17961876

Group type: EXPERIMENTAL
Intervention: DTPw-HBV/Hib 2.5
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tritanrix-Hep B and Hiberix
Number of subjects: 0
Study: 15203788

Group type: EXPERIMENTAL
Intervention: Nicotine withdrawal symptoms
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Withdrawal index
Number of subjects: 191
Study: 11284567

Group type: EXPERIMENTAL
Intervention: Reduction and internal fixation
Number of subjects: 280

Group type: COMPARATOR
Intervention: Cemented Thompson hemiarthroplasty
Number of subjects: 280

Group type: COMPARATOR
Intervention: Cemented Monk bipolar hemiarthroplasty
Number of subjects: 280

Group type: COMPARATOR
Intervention: Cemented hemiarthroplasty
Number of subjects: 280

Group type: COMPARATOR
Intervention: Bipolar prosthesis
Number of subjects: 280
Study: 9842807

Group type: EXPERIMENTAL
Intervention: Information + modeling + coping-based program (OR tour + videotape + child-life preparation)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Information + modeling-based program (OR tour + videotape)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Information-based program (OR tour)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Extensive program (Information + modeling + coping-based)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control groups (Information + modeling-based and Information-based programs)
Number of subjects: 75
Study: 7510746

Group type: EXPERIMENTAL
Intervention: TCR V beta 5.2(39-59) and V beta 6.1(39-59) peptides at low doses (100 to 300 micrograms)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: TCR V beta 5.2(39-59) and V beta 6.1(39-59) peptides
Number of subjects: 11
Study: 2777565

Group type: EXPERIMENTAL
Intervention: One Step Skin Prep
Number of subjects: 60

Group type: COMPARATOR
Intervention: ECG Prep Pads
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 1101065

Group type: EXPERIMENTAL
Intervention: HBIG (high concentration of antibodies to surface components of hepatitis B virus, 442 mug per milliliter)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control human immune globulin preparation
Number of subjects: 58
Study: 31015036

Group type: EXPERIMENTAL
Intervention: Proteogenomic variant database created from pooled sequencing experiments
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Proteogenomic variant database with 4 complete genomes
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Proteogenomic variant database with 26 assemblies
Number of subjects: 137

Group type: COMPARATOR
Intervention: Conventional databases
Number of subjects: 137
Study: 28158993

Group type: COMPARATOR
Intervention: FSGS
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: MCD
Number of subjects: 49
Study: 26485297

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 83

Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 83
Study: 23883377

Group type: EXPERIMENTAL
Intervention: Riociguat
Number of subjects: 261

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 261
Study: 21771261

Group type: EXPERIMENTAL
Intervention: Continuous training (CTr) for 15 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Retraining (RTr) after a 3-week detraining period
Number of subjects: 15
Study: 19650752

Group type: EXPERIMENTAL
Intervention: Alogliptin 12.5 mg
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Alogliptin 25 mg
Number of subjects: 493

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 493

Group type: EXPERIMENTAL
Intervention: Alogliptin
Number of subjects: 493
Study: 16431185

Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study: 15561379

Group type: EXPERIMENTAL
Intervention: Intra-articular analgesics (short acting anaesthetics)
Number of subjects: 219

Group type: COMPARATOR
Intervention: No postoperative analgesia until moderate-to-severe pain was documented
Number of subjects: 219
Study: 11368732

Group type: EXPERIMENTAL
Intervention: Salmeterol (42 microg twice per day)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Triamcinolone (400 microg twice per day)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study: 9164377

Group type: EXPERIMENTAL
Intervention: Protocol intervention (nortriptyline hydrochloride or interpersonal psychotherapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Protocol treatment completion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care with the patient's physician
Number of subjects: 0
Study: 8706197

Group type: EXPERIMENTAL
Intervention: Edrophonium 0.25 mg x kg(‐1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Edrophonium 0.5 mg x kg(‐1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Edrophonium 1.0 mg x kg(‐1)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (0.0 mg x kg(‐1) edrophonium)
Number of subjects: 75
Study: 2243544

Group type: EXPERIMENTAL
Intervention: Computer-based reminders
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two other interventions
Number of subjects: 0
Study: 115159

Group type: EXPERIMENTAL
Intervention: Glibenclamide
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Gliquidone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Glisoxepide
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29279189

Group type: EXPERIMENTAL
Intervention: Calcium carbonate intake with water
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Calcium carbonate intake with orange juice
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Calcium carbonate intake with breakfast
Number of subjects: 12
Study: 27715368

Group type: EXPERIMENTAL
Intervention: Reciprocal imitation training (RIT)
Number of subjects: 20
Study: 28270319

Group type: EXPERIMENTAL
Intervention: Walking in a semi-natural recreational area
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Walking on a treadmill in a gym
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sitting and watching nature-based videos on TV
Number of subjects: 0
Study: 24034810

Group type: EXPERIMENTAL
Intervention: Cutting-Down-Programme (CDP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 80
Study: 21123186

Group type: EXPERIMENTAL
Intervention: Aliskiren
Number of subjects: 1782

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1782
Study: 19484416

Group type: EXPERIMENTAL
Intervention: Three-dimensional analysis of the maxilla in patients with bilateral cleft lip and palate
Number of subjects: 32

Group type: COMPARATOR
Intervention: Eugnathic control group, n=32, mean age 5.02 years
Number of subjects: 32
Study: 17947502

Group type: EXPERIMENTAL
Intervention: Long-duration IH (LDIH) protocol: daily 60-min exposures to normobaric 12% O(2)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Short-duration IH (SDIH) protocol: twelve 5-min bouts of 12% O(2), separated by 5-min bouts of room air, daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Both LDIH and SDIH
Number of subjects: 10
Study: 15139073

Group type: EXPERIMENTAL
Intervention: HEC
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: MEC
Number of subjects: 298

Group type: COMPARATOR
Intervention: Physician/Nurse Predictions
Number of subjects: 298
Study: 11574733

Group type: EXPERIMENTAL
Intervention: Cuprophan membrane
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hemophan membrane
Number of subjects: 12

Group type: COMPARATOR
Intervention: Modified cellulose membrane
Number of subjects: 12
Study: 8679424

Group type: EXPERIMENTAL
Intervention: PEG 4 liters
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sodium phosphate 3 packets plus one microenema
Number of subjects: 80
Study: 1889968

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (Voltaren)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Nifedipine (Nidilat)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Tropenzilium bromide (Palerol)
Number of subjects: 49
Study: 6830410

Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (average, 40 mg/day for up to four years)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Adjunctive thioridazine hydrochloride (mean, 87 mg/day)
Number of subjects: 86

Group type: COMPARATOR
Intervention: General population norms
Number of subjects: 86
Study: 30609411

Group type: EXPERIMENTAL
Intervention: Caralluma fimbriata extract (CFE) 500 mg b.d. (n = 49)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo 500 mg b.d. (n = 48)
Number of subjects: 97
Study: 29982386

Group type: EXPERIMENTAL
Intervention: Endoscopic submucosal dissection (ESD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endoscopic mucosal resection (EMR)
Number of subjects: 0
Study: 26540363

Group type: EXPERIMENTAL
Intervention: Microthread design on coronal portion of the fixture (Implantium)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Without microthread design (Superline)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (Microthread and Control)
Number of subjects: 30
Study: 24123098

Group type: EXPERIMENTAL
Intervention: Intensive low-density lipoprotein (LDL)‐lowering therapy with LDL‐apheresis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard statin therapy
Number of subjects: 0
Study: 22958580

Group type: EXPERIMENTAL
Intervention: succinylcholine
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: vecuronium
Number of subjects: 96

Group type: COMPARATOR
Intervention: no muscle relaxant
Number of subjects: 96
Study: 18840313

Group type: EXPERIMENTAL
Intervention: 2% glucose solution
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10% glucose solution
Number of subjects: 12
Study: 17993364

Group type: EXPERIMENTAL
Intervention: diclofenac 50 mg twice daily and placebo manipulative therapy
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: spinal manipulative therapy and placebo drug
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: diclofenac 50 mg twice daily and spinal manipulative therapy
Number of subjects: 240

Group type: COMPARATOR
Intervention: double placebo
Number of subjects: 240
Study: 16307219

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted colectomy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open colectomy
Number of subjects: 60
Study: 11942978

Group type: EXPERIMENTAL
Intervention: Intravesical BCG therapy (102 patients)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Transurethral resection alone (53 patients)
Number of subjects: 155
Study: 9706930

Group type: EXPERIMENTAL
Intervention: 25-gauge Whitacre spinal needle
Number of subjects: 30

Group type: COMPARATOR
Intervention: 25-gauge Quincke spinal needle
Number of subjects: 30
Study: 7871143

Group type: EXPERIMENTAL
Intervention: Active intervention (telephone reminder from the nurse plus written materials)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Passive intervention (letter and leaflet encouraging immunisation)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Passive intervention
Number of subjects: 239
Study: 2406439

Group type: EXPERIMENTAL
Intervention: Cefoxitin prophylaxis (3 doses of 2g each: initial dose after cord clamping, subsequent doses at 4 and 8 hours)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefoxitin prophylaxis
Number of subjects: 0